RT-PCR and western blotting showed that expression levels of HBx and IGF2BP2 were upregulated in 50 HCC tissues that showed downregulated miR-216b expression (Figure 4a). The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.